Molecular cytogenetic characterization of t(14;19)(q32;p13), a new recurrent translocation in B cell malignancies

Virchows Archiv

Volumn 450, Issue 5, 2007, Pages 559-565

  Micci, Francesca ^a   Panagopoulos, Ioannis ^b   Tjønnfjord, Geir E ^a,c   Kolstad, Arne ^a   Delabie, Jan ^a   Beiske, Klaus ^a   Heim, Sverre ^a,c  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

ALL; BRD4; Cytogenetics; Large B cell lymphoma; t(14; 19)(q32; p13)

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; IMMUNOGLOBULIN HEAVY CHAIN; METHOTREXATE; PREDNISOLONE; VINCRISTINE;

ADOLESCENT; ADULT; ANAMNESIS; ARTICLE; B CELL LYMPHOMA; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CARCINOGENESIS; CASE REPORT; CHROMOSOME 14Q; CHROMOSOME 19P; CHROMOSOME ANALYSIS; CHROMOSOME BREAKAGE; CHROMOSOME G BAND; CHROMOSOME TRANSLOCATION; CLINICAL FEATURE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; KARYOTYPE; MALE; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; QUALITATIVE ANALYSIS;

ADOLESCENT; ADULT; CHROMOSOMES, HUMAN, PAIR 14; CHROMOSOMES, HUMAN, PAIR 19; COMBINED MODALITY THERAPY; CYTOGENETICS; FEMALE; GENES, IMMUNOGLOBULIN HEAVY CHAIN; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, B-CELL, ACUTE; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL; MALE; MEDIASTINAL NEOPLASMS; MOLECULAR DIAGNOSTIC TECHNIQUES; SPECTRAL KARYOTYPING; TRANSLOCATION, GENETIC; TREATMENT OUTCOME;

EID: 34247639534     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-007-0407-6     Document Type: Article

References (30)

1. Adhikary S, Eilers M (2005) Transcriptional regulation and transformation by Myc proteins. Nat Rev Mol Cell Biol 6:635-645
2. Au WY, Horsman DE, Ohno H, Klasa RJ, Gascoyne RD (2002) Bcl-3/IgH translocation (14;19)(q32;q13) in non-Hodgkin's lymphomas. Leuk Lymphoma 43:813-816
3. Axelson H (2004) Notch signaling and cancer: emerging complexity. Semin Cancer Biol 14:317-319
4. Bellavia D, Campese AF, Checquolo S, Balestri A, Biondi A, Cazzaniga G, Lendahl U, Fehling HJ, Hayday AC, Frati L, von Boehmer H, Gulino A, Screpanti I (2002) Combined expression of pTalpha and Notch3 in T cell leukemia identifies the requirement of preTCR for leukemogenesis. Proc Natl Acad Sci USA 99:3788-3793
5. Bene MC, Castoldi G, Knapp W, Ludwig WD, Matutes E, Orfao A, van't Veer MB (1995) Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia 9:1783-1786
6. Campbell LJ (2005) Cytogenetics of lymphomas. Pathology 37:493-507
7. Czepulkowski B, Gibbons B (2001) Cytogenetics in acute lymphoblastic leukemia. In: Rooney DE (ed) Human cytogenetics: malignancy and acquired abnormalities. Oxford University Press, Oxford, pp 57-85
8. Dang TP, Gazdar AF, Virmani AK, Sepetavec T, Hande KR, Minna JD, Roberts JR, Carbone DP (2000) Chromosome 19 translocation, overexpression of Notch3, and human lung cancer. J Natl Cancer Inst 92:1355-1357
9. Douet-Guilbert N, Morel F, Le Bris MJ, Herry A, Le Calvez G, Marion V, Abgrall JF, Berthou C, De Braekeleer M (2004) Cytogenetic studies in T-cell acute lymphoblastic leukemia (1981-2002). Leuk Lymphoma 45:287-290
10. Evensen SA, Brinch L, Tjonnfjord G, Stavem P, Wisloff F (1994) Estimated 8-year survival of more than 40% in a population-based study of 79 adult patients with acute lymphoblastic leukaemia. Br J Haematol 88:88-93
11. Finn WG, Thangavelu M, Yelavarthi KK, Goolsby CL, Tallman MS, Traynor A, Peterson LC (1996) Karyotype correlates with peripheral blood morphology and immunophenotype in chronic lymphocytic leukemia. Am J Clin Pathol 105:458-467
12. French CA, Kutok JL, Faquin WC, Toretsky JA, Antonescu CR, Griffin CA, Nose V, Vargas SO, Moschovi M, Tzortzatou-Stathopoulou F, Miyoshi I, Perez-Atayde AR, Aster JC, Fletcher JA (2004) Midline carcinoma of children and young adults with NUT rearrangement. J Clin Oncol 22:4135-4139
13. French CA, Miyoshi I, Aster JC, Kubonishi I, Kroll TG, Dal Cin P, Vargas SO, Perez-Atayde AR, Fletcher JA (2001) BRD4 bromodomain gene rearrangement in aggressive carcinoma with translocation t(15;19). Am J Pathol 159:1987-1992
14. French CA, Miyoshi I, Kubonishi I, Grier HE, Perez-Atayde AR, Fletcher JA (2003) BRD4-NUT fusion oncogene: a novel mechanism in aggressive carcinoma. Cancer Res 63:304-307
15. Haruki N, Kawaguchi KS, Eichenberger S, Massion PP, Gonzalez A, Gazdar AF, Minna JD, Carbone DP, Dang TP (2005) Cloned fusion product from a rare t(15;19)(q13.2;p13.1) inhibit S phase in vitro. J Med Genet 42:558-564
16. Heim S, Mitelman F (eds) (1995) Cancer cytogenetics. Wiley-Liss, New York
17. Shaffer LG, Tommerup N (eds) (2005) ISCN 2005: an international system for human cytogenetic nomenclature. S Karger, Basel
18. Kearny L, Hammomd DW (2001) Molecular cytogenetic technologies. In: Rooney DE (ed) Human cytogenetics-malignancy and acquired abnormalities. Oxford University Press, Oxford, pp 129-163
19. Martinez-Climent JA, Sanchez-Izquierdo D, Sarsotti E, Blesa D, Benet I, Climent J, Vizcarra E, Marugan I, Terol MJ, Sole F, Cigudosad JC, Siebert R, Dyer MJ, Garcia-Conde J (2003) Genomic abnormalities acquired in the blastic transformation of splenic marginal zone B-cell lymphoma. Leuk Lymphoma 44:459-464
20. Maruyama T, Farina A, Dey A, Cheong J, Bermudez VP, Tamura T, Sciortino S, Shuman J, Hurwitz J, Ozato K (2002) A Mammalian bromodomain protein, brd4, interacts with replication factor C and inhibits progression to S phase. Mol Cell Biol 22:6509-6520
21. McKeithan TW, Takimoto GS, Ohno H, Bjorling VS, Morgan R, Hecht BK, Dube I, Sandberg AA, Rowley JD (1997) BCL3 rearrangements and t(14;19) in chronic lymphocytic leukemia and other B-cell malignancies: a molecular and cytogenetic study. Genes Chromosomes Cancer 20:64-72
22. Mitelman, F., Johansson, B., Mertens, F. (2006) Mitelman database of chromosome aberrations in cancer. http://cgap.nci.nih.gov/Chromosomes/Mitelman
23. Ohno H, Doi S, Yabumoto K, Fukuhara S, McKeithan TW (1993) Molecular characterization of the t(14;19)(q32;q13) translocation in chronic lymphocytic leukemia. Leukemia 7:2057-2063
24. Popescu NC, Zimonjic DB (2002) Chromosome-mediated alterations of the MYC gene in human cancer. J Cell Mol Med 6:151-159
25. Robinson HM, Taylor KE, Jalali GR, Cheung KL, Harrison CJ, Moorman AV (2004) t(14;19)(q32;q13): a recurrent translocation in B-cell precursor acute lymphoblastic leukemia. Genes Chromosomes Cancer 39:88-92
26. Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor
27. Schlegelberger B, Weber-Matthiesen K, Himmler A, Bartels H, Sonnen R, Kuse R, Feller AC, Grote W (1994) Cytogenetic findings and results of combined immunophenotyping and karyotyping in Hodgkin's disease. Leukemia 8:72-80
28. Sonoki T, Willis TG, Oscier DG, Karran EL, Siebert R, Dyer MJ (2004) Rapid amplification of immunoglobulin heavy chain switch (IGHS) translocation breakpoints using long-distance inverse PCR. Leukemia 18:2026-2031
29. Willis TG, Jadayel DM, Coignet LJ, Abdul-Rauf M, Treleaven JG, Catovsky D, Dyer MJ (1997) Rapid molecular cloning of rearrangements of the IGHJ locus using long-distance inverse polymerase chain reaction. Blood 90:2456-2464
30. Zagouras P, Stifani S, Blaumueller CM, Carcangiu ML, Artavanis-Tsakonas S (1995) Alterations in Notch signaling in neoplastic lesions of the human cervix. Proc Natl Acad Sci USA 92:6414-6418